Niigata University Medical & Dental Hospital   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Niigata Japan (1910)

Organization Overview

First Clinical Trial
2003
NCT00190476
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Department of Internal Medicine, Niigata Cancer Center Hospital | Niigata Medical Center | Niigata University Medical & Dental Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 3)

Fibrosis (Phase 2)

Gastrointestinal Stromal Tumors (Phase 2)

Liver Cirrhosis (Phase 2)

Lung Neoplasms (Phase 3)

Neoplasm Metastasis (Phase 2)

Pulmonary Alveolar Proteinosis (Phase 2)

Respiratory Aspiration (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 7